Skip to content
Back to announcement

20260515_SCPI_Pengumuman RUPS_32091383_lamp1.pdf

RUPS notice Needs review SCPI

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 2

Page 1
PT. Organon Pharma Indonesia Tbk.
Sinarmas MSIG Tower, 37th Floor Unit 102 & 106
JL. Jend. Sudirman Kav. 21, Setiabudi , Jakarta Selatan
DKI Jakarta-12920
Phone No (62) 21-31107000
www.organon.com




                                                PT ORGANON PHARMA INDONESIA TBK
                                                         PENGUMUMAN
                                              RAPAT UMUM PEMEGANG SAHAM TAHUNAN
                                                             DAN
                                             RAPAT UMUM PEMEGANG SAHAM LUAR BIASA


Dengan ini diumumkan kepada para Pemegang Saham PT Organon Pharma Indonesia Tbk (“Perseroan”),
berkedudukan di Sinarmas MSIG Tower, Lantai 37 Unit 102 & 106 Jl. Jend. Sudirman Kav. 21 Setiabudi, Jakarta
Selatan, DKI Jakarta, bahwa Perseroan akan menyelenggarakan Pemegang Saham Perseroan untuk
menghadiri Rapat Umum Pemegang Saham Tahunan (“RUPST”) dan Rapat Umum Pemegang Saham Luar
Biasa (selanjutnya disebut “RUPSLB”) (selanjutnya disebut “Rapat”) di Jakarta pada hari Selasa, 23 Juni 2026.

Sesuai dengan ketentuan dalam Pasal 10 ayat 5 Anggaran Dasar Perseroan serta memperhatikan Peraturan
Otoritas Jasa Keuangan Nomor 15/POJK.04/2020 tentang Rencana dan Penyelenggaraan Rapat Umum
Pemegang Saham Perusahaan Terbuka (“POJK No. 15”), Pemanggilan Rapat akan dilakukan pada 1 Juni 2026
melalui situs web Bursa Efek Indonesia, dan situs web Perseroan.

Yang berhak menghadiri/mewakili dalam Rapat adalah Pemegang Saham Perseroan yang namanya tercatat
dalam Daftar Pemegang Saham Perseroan pada tanggal 29 Mei 2026, pukul 16.00 Waktu Indonesia Barat
(WIB) atau pemilik saham Perseroan pada sub rekening efek PT Kustodian Sentral Efek Indonesia (KSEI) pada
penutupan perdagangan saham di Bursa Efek Indonesia (BEI) tanggal 29 Mei 2026, pukul 16.00 WIB.

Seorang Pemegang Saham atau lebih yang (bersama-sama) mewakili 1/20 (satu per duapuluh) atau lebih dari
jumlah seluruh saham Perseroan dengan hak suara yang sah yang telah dikeluarkan oleh Perseroan dapat
mengajukan usulan mata acara Rapat. Usulan Pemegang Saham Perseroan tersebut akan dimasukan dalam
mata acara Rapat jika memenuhi ketentuan Pasal 10 ayat 21 Anggaran Dasar Perseroan dan Pasal 16 POJK
No. 15, yakni:
1. Usul tersebut diajukan tertulis dan diterima Direksi Perseroan paling lambat tanggal 25 Mei 2026 pukul
     16.00 Waktu Indonesia Barat;
2. Disertai alasan dan bahan usulan mata acara Rapat;
3. Usul tersebut merupakan mata acara yang membutuhkan Keputusan Rapat serta tidak bertentangan
     dengan peraturan perundang-undangan; dan
4. Usul tersebut dilakukan dengan itikad baik, mempertimbangkan kepentingan Perseroan dan berhubungan
     langsung dengan usaha Perseroan.


Pengumuman Rapat ini juga dapat diakses pada situs web PT Kustodian Sentral Efek Indonesia
(www.ksei.co.id), situs web Bursa Efek Indonesia (www.idx.co.id), dan situs web Perseroan
(https://www.organon.com/indonesia/).



                                                            Jakarta, 15 Mei 2026
                                                     PT ORGANON PHARMA INDONESIA Tbk
                                                                  Direksi
Page 2
PT. Organon Pharma Indonesia Tbk.
Sinarmas MSIG Tower, 37th Floor Unit 102 & 106
JL. Jend. Sudirman Kav. 21, Setiabudi , Jakarta Selatan
DKI Jakarta-12920
Phone No (62) 21-31107000
www.organon.com




                                            PT ORGANON PHARMA INDONESIA TBK
                                                  ANNOUNCEMENT OF THE
                                        ANNUAL GENERAL MEETING OF SHAREHOLDERS
                                                         AND
                                      EXTRAORDINARY GENERAL MEETING SHAREHOLDERS


It is hereby announced to the Shareholders of PT Organon Pharma Indonesia Tbk (the "Company"), domiciled
at Sinarmas MSIG Tower, 37th Floor Unit 102 & 106 Jl. Jend. Sudirman Kav. 21 Setiabudi, Jakarta Selatan,
DKI Jakarta, that the Company will hold an Annual General Meeting of Shareholders (“AGMS”) and
Extraordinary General Meeting of Shareholders (“EGMS”) (hereinafter referred to as the "Meeting") in Jakarta
on Tuesday, 23 June 2026.

In accordance with the provisions of Article 10 paragraph 5 of the Company's Articles of Association and
Financial Services Authority Regulation Number 15/POJK.04/2020 concerning Plans and Implementation of
General Meeting of Shareholders of Public Companies ("POJK No. 15"), the invitation to the Meeting will be
made on 1 June 2026 through the website of the Indonesia Stock Exchange, and the Company's website.

Those entitled to attend/represent the Meeting are the Company's Shareholders whose names are registered
in the Company's Shareholders Register on 29 May 2026, 16.00 Western Indonesia Time (WIB) or the
Company's shareholders in the securities sub account PT Kustodian Sentral Efek Indonesia (KSEI) at the close
of trading day on the Indonesia Stock Exchange (IDX) on 29 May 2025, 16.00 WIB.

One or more Shareholders who (together) represent 1/20 (one twentieth) or more of the total number of shares
of the Company with valid voting rights that have been issued by the Company may propose a meeting agenda.
The proposal of the Company's Shareholders will be included in the agenda of the Meeting if it meets the
provisions of Article 10 paragraph 3 of the Company's Articles of Association and Article 16 of POJK No. 15,
namely:
  1. The proposal must be submitted in writing and received by the Board of Directors of the Company no
       later than 25 May 2026 at 16.00 Western Indonesia Time;
  2. The proposal must be accompanied by the reasons and supporting materials for the proposed meeting
       agenda item;
  3. The proposal must constitute an agenda item that requires a resolution of the Meeting and must not
       conflict with the prevailing laws and regulations; and
  4. The proposal must be submitted in good faith, taking into account the interests of the Company, and must
       be directly related to the Company’s business activities.

The announcement of this Meeting can also be accessed on the website of the Indonesian Central Securities
Depository (www.ksei.co.id), the website of the Indonesia Stock Exchange (www.idx.co.id), and the Company's
website (https://www.organon.com/indonesia/).

                                                            Jakarta, 15 May 2026
                                                     PT ORGANON PHARMA INDONESIA Tbk
                                                             Board of Directors

File

File Open PDF
Source IDX
Size0.22 MB
Published15 May 2026
Pages2
Characters6,588
Text sourceEmbedded text layer
OCR confidence—

Names mentioned 7 people and organisations named in the text · linked when the evidence is strong

linked org Organon Pharma Indonesia Tbk. p.1 ×23
linked org Jakarta Selatan DKI Jakarta- p.1 ×4
possible org Otoritas Jasa Keuangan p.1
possible org Bursa Efek Indonesia p.1 ×3
unresolved org PT Kustodian Sentral Efek Indonesia p.1 ×5
unresolved org Financial Services Authority p.2
unresolved org Indonesia Stock Exchange p.2 ×3

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

Rule parser Needs review confidence 0.222 191 ms 12 Sep 2026 19:24
Raw output
{'agenda': [],
 'is_electronic': False,
 'meeting_date': '2026-06-23',
 'meeting_type': 'EGM'}

Other files in this announcement 1

↑↓ select ↵ open ⇧↵ see every result